- Hem
- Om universitetet
- Hitta person
- Svein Olav Bratlie
Svein Olav Bratlie
Anknuten till forskning
Avd för kirurgiOm Svein Olav Bratlie
Consultant surgeon, PhD
Current project: Aspects on pancreatic cancer. Clinikal trials: NorPACT-1, PANCEP-1
PREOPANC-3. En studie om värdet att ge cytostatikabehandling inför kurativt syftande kirurgi vid bukspottkörtelcancer, får nu VR-bidrag till forskningsmiljö på totalt 8 280 000 miljoner kronor under fyra år. Läs mer om projeket - Cellgiftsbehandling före operation kan öka chanserna vid bukspottkörtelcancer
-
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic
Cancer
Hanna Grauers Wiktorin, Ebru Aydin, Roberta Kiffin, Caroline Vilhav, Johan Bourghardt Fagman, Mustafa Kaya, Sanchari Paul, Beatrice Westman, Svein-Olav Bratlie, Peter Naredi, Kristoffer Hellstrand, Anna Martner
Cancer research communications - 2024 -
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2
trial
Knut Jorgen Labori, Svein-Olav Bratlie, Bodil Andersson, Jon-Helge Angelsen, Christina Biörserud, Bergthor Bjornsson, Erling Audun Bringeland, Nils Elander, Herish Garresori, Jon Erik Gronbech, Johan Haux, Oskar Hemmingsson, Maria Gustafsson Liljefors, Tor Age Myklebust, Linn Save Nymo, Katriina Peltola, Per Pfeiffer, Ville Sallinen, Per Sandstrom, Ernesto Sparrelid, Helge Stenvold, Kjetil Soreide, Bobby Tingstedt, Caroline Verbeke, Daniel Ohlund, Leif Klint, Svein Dueland, Kristoffer Lassen
LANCET GASTROENTEROLOGY & HEPATOLOGY - 2024 -
PACADI: translation and adaptation of a Swedish-language version of the pancreatic cancer disease impact
score
Thomas K. Andersson, Monika Fagevik Olsén, Micheline Al Nouh, Svein-Olav Bratlie
Bmc Research Notes - 2022 -
Resectable, borderline, and locally advanced pancreatic cancer-"the good, the bad, and the ugly" candidates for
surgery?
Svein-Olav Bratlie, Johanna Wennerblom, Caroline Vilhav, Jan Persson, Elena Rangelova
Journal of Gastrointestinal Oncology - 2021 -
How to select the most appropriate adjuvant treatment after neoadjuvant treatment and resection for locally advanced pancreatic
cancer?
Elena Rangelova, Svein-Olav Bratlie
Journal of Gastrointestinal Oncology - 2021 -
Proteomic Approach to the Potential Role of Angiotensin II in Barrett
Dysplasia
Svein-Olav Bratlie, Ville Wallenius, Anders Edebo, Lars Fändriks, Anna Casselbrant
Proteomics - Clinical Applications - 2019 -
Support for involvement of the renin-angiotensin system in dysplastic Barrett's
esophagus
Svein-Olav Bratlie, Anna Casselbrant, Anders Edebo, Lars Fändriks
Scandinavian Journal of Gastroenterology - 2017 -
The renin–angiotensin system in Barrett’s
esophagus
Svein-Olav Bratlie, Anders Edebo, Anna Casselbrant, Herbert F Helander, Lars Fändriks
Scandinavian Journal of Gastroenterology - 2016 -
Multiple-Band Imaging Provides Better Value Than White-light Endoscopy in Detection of Dysplasia in Patients With
Barrett's Esophagus.
Svein-Olav Bratlie, Erik Johnsson, Claes Jönsson, Lars Fändriks, Anders Edebo
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 2014 -
The renin-angiotensin system in the esophageal mucosa of healthy subjects and patients with reflux
disease
Eleonora Björkman, Anders Edebo, Anna Casselbrant, Herbert F Helander, Svein-Olav Bratlie, Vieth Michael, Lars Fändriks
Scandinavian Journal of Gastroenterology - 2013 -
Is transcatheter arterial embolization a safer alternative than surgery when endoscopic therapy fails in bleeding duodenal
ulcer?
Linas Venclauskas, Svein-Olav Bratlie, Karin Zachrisson, Almantas Maleckas, Juozas Pundzius, Claes Jönson
Scandinavian journal of gastroenterology - 2010